This compound is primarily utilized in the field of organic synthesis, particularly as a key intermediate in the development of pharmaceuticals. Its boronic acid moiety makes it valuable in Suzuki-Miyaura cross-coupling reactions, which are widely employed to construct carbon-carbon bonds in the synthesis of complex organic molecules, including drug candidates. The cyclohexylamino group enhances its potential as a building block for designing molecules with specific biological activities, such as enzyme inhibitors or receptor modulators. Additionally, the fluorine substitution on the phenyl ring can influence the compound's metabolic stability and binding affinity, making it useful in medicinal chemistry for optimizing drug properties. Its hydrochloride form ensures improved solubility and handling in various synthetic processes.